# US 2026/0062446 A1 · Scalable synthesis of anabaenopeptins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062446 A1
- Document ID: US20260062446A1
- Status: Published application
- Kind: A1
- Application number: 19/311,628
- Filed: 2025-08-27
- Published: 2026-03-05
- Earliest claimed: 2024-08-27
- Assignees: Wayne State University
- Applicants: Wayne State University
- Inventors: Jeremy Jacob KODANKO; Judy A. WESTRICK; Megan Lee QUANDT
- Web page: https://patentgrep.com/patent/US20260062446A1

## CPC

- C07K 7/56: the cyclisation not occurring through 2,4-diamino-butanoic acid
- C07K 7/06: having 5 to 11 amino acids
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

A compound having formula I that is useful for preparing an anabaenopeptin or derivatives thereof is provided: or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof, wherein: X1, X2, X3, and X4 are alkyl, aryl, hydroxyl, alkyl phenyl, alkyl phenol, and benzyl groups; and R1, R2, R3, R4, and R5 are H or C1-10 alkyl, wherein at least one of X1, X2, X3, and X4 is alkyl phenol, with the proviso that at least one of X1, X2, X3, and X4 are alkyl phenol.

## Claims

### Claim 1

A compound having formula 1:
or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof,
wherein:
X1, X2, X3, and X4 are alkyl, aryl, hydroxyl, alkyl phenyl, alkyl phenol, and benzyl groups; and
R1, R2, R3, R4, and R5 are H or C1-10 alkyl, wherein at least one of X1, X2, X3, and X4 is alkyl phenol, with the proviso that at least one of X1, X2, X3, and X4 are alkyl phenol.

### Claim 2 (depends on 1)

The compound of claim 1, wherein at least two of X1, X2, X3, and X4 are alkyl phenol.

### Claim 3 (depends on 1)

The compound of claim 1, wherein the alkyl phenol is

### Claim 4 (depends on 1)

The compound of claim 1, wherein X1 is isopropyl.

### Claim 5 (depends on 1)

The compound of claim 1, wherein X2 and/or X3 is p-hydroxybenzyl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein X3 is methyl.

### Claim 7 (depends on 1)

The compound of claim 1, wherein X4 is benzyl.

### Claim 8 (depends on 1)

The compound of claim 1, wherein X1 is isopropyl, X2 is p-hydroxybenzyl, X3 is methyl, and X4 is benzyl.

### Claim 9 (depends on 1)

The compound of claim 1, wherein 1 to 3 of R1, R2, R3, R4, and R5 are H, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, or isohexyl.

### Claim 10 (depends on 1)

The compound of claim 1, wherein at least one of X1, X2, X3, and X4 are not one of hydroxymethyl, hydroxyethyl, thiol, thioether, p-hydroxybenzyl, indolylmethyl, carboxymethyl, carboxyethyl, carboxamide, carboxyethylamide, butylammonium, guanidinium, imidazolylmethyl, or pyrrolidine.

### Claim 11 (depends on 1)

The compound of claim 1 having formula II:
or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof.

### Claim 12 (depends on 1)

The compound of claim 1, wherein the isotopic variations include
hydrogen isotopes selected from the group consisting of protium (1H), deuterium (2H), tritium (3H), and combinations thereof; and/or
carbon isotopes selected from the group consisting of carbon-12 (12C), carbon-13 (13C), carbon-14 (14C), and combinations thereof; and/or
oxygen isotopes selected from the group consisting of oxygen-16 (16O), oxygen-17 (17O), oxygen-18 (18O), and combinations thereof; and/or
nitrogen isotopes selected from the group consisting of nitrogen-14 (14N), nitrogen-15 (15N), and combinations thereof.

### Claim 13 (depends on 1)

A method for making the compound of claim 1 comprising preparing a pentapeptide that includes residues of amino acids having the following formula:
with the proviso that at least one of X1, X2, X3, and X4 are alkyl phenol; and
cyclizing the pentapeptide to form the compound having formula (I).

### Claim 14 (depends on 13)

The method of claim 13, wherein the pentapeptide is selected form the group consisting of H2N-A1-A2-A3-A4-A5-CO2H; H2N-A1-A2-A3-A5-A4-CO2H; H2N-A1-A2-A4-A3-A5-CO2H; NH2-A1-A2-A4-A5-A3-CO2H; A1-A2-A5-A3-A4-CO2H; NH2-A1-A2-A5-A4-A3-CO2H; NH2-A1-A3-A2-A4-A5-CO2H; NH2-A1-A3-A2-A5-A4-CO2H; NH2-A1-A3-A4-A2-A5-CO2H; NH2-A1-A3-A4-A5-A2-CO2H; NH2-A1-A3-A5-A2-A4-CO2H; NH2-A1-A3-A5-A4-A2-CO2H; NH2-A1-A4-A2-A3-A5-CO2H; NH2-A1-A4-A2-A5-A3-CO2H; NH2-A1-A4-A3-A2-A5-CO2H; NH2-A1-A4-A3-A5-A2-CO2H; NH2-A1-A4-A5-A2-A3-CO2H; NH2-A1-A4-A5-A3-A2-CO2H; NH2-A1-A5-A2-A3-A4-CO2H; NH2-A1-A5-A2-A4-A3-CO2H; NH2-A1-A5-A3-A2-A4-CO2H; NH2-A1-A5-A3-A4-A2-CO2H; NH2-A1-A5-A4-A2-A3-CO2H; NH2-A1-A5-A4-A3-A2-CO2H; NH2-A2-A1-A3-A4-A5-CO2H; NH2-A2-A1-A3-A5-A4-CO2H; NH2-A2-A1-A4-A3-A5-CO2H; NH2-A2-A1-A4-A5-A3-CO2H; NH2-A2-A1-A5-A3-A4-CO2H; NH2-A2-A1-A5-A4-A3-CO2H; NH2-A2-A3-A1-A4-A5-CO2H; NH2-A2-A3-A1-A5-A4-CO2H; NH2-A2-A3-A4-A1-A5-CO2H; NH2-A2-A3-A4-A5-A1-CO2H; NH2-A2-A3-A5-A1-A4-CO2H; NH2-A2-A3-A5-A4-A1-CO2H; NH2-A2-A4-A1-A3-A5-CO2H; NH2-A2-A4-A1-A5-A3-CO2H; NH2-A2-A4-A3-A1-A5-CO2H; NH2-A2-A4-A3-A5-A1-CO2H; NH2-A2-A4-A5-A1-A3-CO2H; NH2-A2-A4-A5-A3-A1-CO2H; NH2-A2-A5-A1-A3-A4-CO2H; NH2-A2-A5-A1-A4-A3-CO2H; NH2-A2-A5-A3-A1-A4-CO2H; NH2-A2-A5-A3-A4-A1-CO2H; NH2-A2-A5-A4-A1-A3-CO2H; NH2-A2-A5-A4-A3-A1-CO2H; NH2-A3-A1-A2-A4-A5-CO2H; NH2-A3-A1-A2-A5-A4-CO2H; NH2-A3-A1-A4-A2-A5-CO2H; NH2-A3-A1-A4-A5-A2-CO2H; NH2-A3-A1-A5-A2-A4-CO2H; NH2-A3-A1-A5-A4-A2-CO2H; NH2-A3-A2-A1-A4-A5-CO2H; NH2-A3-A2-A1-A5-A4-CO2H; NH2-A3-A2-A4-A1-A5-CO2H; NH2-A3-A2-A4-A5-A1-CO2H; NH2-A3-A2-A5-A1-A4-CO2H; NH2-A3-A2-A5-A4-A1-CO2H; NH2-A3-A4-A1-A2-A5-CO2H; NH2-A3-A4-A1-A5-A2-CO2H; NH2-A3-A4-A2-A1-A5-CO2H; NH2-A3-A4-A2-A5-A1-CO2H; NH2-A3-A4-A5-A1-A2-CO2H; NH2-A3-A4-A5-A2-A1-CO2H; NH2-A3-A5-A1-A2-A4-CO2H; NH2-A3-A5-A1-A4-A2-CO2H; NH2-A3-A5-A2-A1-A4-CO2H; NH2-A3-A5-A2-A4-A1-CO2H; NH2-A3-A5-A4-A1-A2-CO2H; NH2-A3-A5-A4-A2-A1-CO2H; NH2-A4-A1-A2-A3-A5-CO2H; NH2-A4-A1-A2-A5-A3-CO2H; NH2-A4-A1-A3-A2-A5-CO2H; NH2-A4-A1-A3-A5-A2-CO2H; NH2-A4-A1-A5-A2-A3-CO2H; NH2-A4-A1-A5-A3-A2-CO2H; NH2-A4-A2-A1-A3-A5-CO2H; NH2-A4-A2-A1-A5-A3-CO2H; NH2-A4-A2-A3-A1-A5-CO2H; NH2-A4-A2-A3-A5-A1-CO2H; NH2-A4-A2-A5-A1-A3-CO2H; NH2-A4-A2-A5-A3-A1-CO2H; NH2-A4-A3-A1-A2-A5-CO2H; NH2-A4-A3-A1-A5-A2-CO2H; NH2-A4-A3-A2-A1-A5-CO2H; NH2-A4-A3-A2-A5-A1-CO2H; NH2-A4-A3-A5-A1-A2-CO2H; NH2-A4-A3-A5-A2-A1-CO2H; NH2-A4-A5-A1-A2-A3-CO2H; NH2-A4-A5-A1-A3-A2-CO2H; NH2-A4-A5-A2-A1-A3-CO2H; NH2-A4-A5-A2-A3-A1-CO2H; NH2-A4-A5-A3-A1-A2-CO2H; NH2-A4-A5-A3-A2-A1-CO2H; NH2-A5-A1-A2-A3-A4-CO2H; NH2-A5-A1-A2-A4-A3-CO2H; NH2-A5-A1-A3-A2-A4-CO2H; NH2-A5-A1-A3-A4-A2-CO2H; NH2-A5-A1-A4-A2-A3-CO2H; NH2-A5-A1-A4-A3-A2-CO2H; NH2-A5-A2-A1-A3-A4-CO2H; NH2-A5-A2-A1-A4-A3-CO2H; NH2-A5-A2-A3-A1-A4-CO2H; NH2-A5-A2-A3-A4-A1-CO2H; NH2-A5-A2-A4-A1-A3-CO2H; NH2-A5-A2-A4-A3-A1-CO2H; NH2-A5-A3-A1-A2-A4-CO2H; NH2-A5-A3-A1-A4-A2-CO2H; NH2-A5-A3-A2-A1-A4-CO2H; NH2-A5-A3-A2-A4-A1-CO2H; NH2-A5-A3-A4-A1-A2-CO2H; NH2-A5-A3-A4-A2-A1-CO2H; NH2-A5-A4-A1-A2-A3-CO2H; NH2-A5-A4-A1-A3-A2-CO2H; NH2-A5-A4-A2-A1-A3-CO2H; NH2-A5-A4-A2-A3-A1-CO2H; NH2-A5-A4-A3-A1-A2-CO2H; and NH2-5-A4-A3-A2-A1 where “-” between any 2 of A1, A2, A3, A4, and A5-represents a peptide bond.

### Claim 15 (depends on 1)

A method for making the compound of claim 1 comprising:
a) providing a first protected amino acid having formula P1 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:
wherein P1 is a first protecting group and P2 is a second protecting group that can be selectively removed under different conditions;
b) attaching a second protected amino acid to the C-terminus side of the first protected amino acid having formula P1 and then removing protecting group P2 to form a peptide having formula P2 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof with an exposed amino group:
wherein Y1 is X1 or X1 with a removable protecting group and OR is a C1-6 alkoxyl protecting group;
c) attaching a third protected amino acid to the exposed amino group to form a peptide having formula P3 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:
wherein Y4 is X4 or a X4 with a removable protecting group and P3 is a third protecting group;
d) removing P4 and attaching a fourth protected amino acid to the N-terminus side of the peptide having formula P3 to form a peptide having formula P4 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:
wherein Y3 is X3 or a X3 with a removable protecting group and P4 is a fourth protecting group;
e) removing P4 and attaching fifth protected amino acid to the N-terminus side of the peptide having formula 34 to form a peptide having formula 5 a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:
wherein Y2 is X2 or a X2 with a removable protecting group and P5 is a fifth protecting group;
f) removing OR and P5 to form pentapeptide P6 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:
and
g) cyclizing the peptide having formula P5 to form pentacycle peptide having formula P7 or a salt thereof and/or stereoisomers thereof and/or isotopic variations thereof:

### Claim 16 (depends on 15)

The method of claim 15 further comprising removing any protective groups from Y1, Y2, Y3, and Y4 to form:

### Claim 17 (depends on 15)

The method of claim 15, wherein P1 is removeable under different conditions that P2, P3, P4, and P5.

### Claim 18 (depends on 15)

The method of claim 15, wherein P1 is carbobenzyloxy and P2, P3, P4, and P5 are tert-butoxycarbonyl.

### Claim 19 (depends on 15)

The method of claim 15, wherein Y1 is isopropyl.

### Claim 20 (depends on 15)

The method of claim 15, wherein Y2 is a protected p-hydroxybenzyl.

### Claim 21 (depends on 15)

The method of claim 15, wherein Y3 is methyl.

### Claim 22 (depends on 15)

The method of claim 15, wherein Y4 is benzyl.

### Claim 23 (depends on 1)

A method for forming an anabaenopeptin or derivative thereof, the method comprising:
a) reacting the compound of claim 1 with a compound having formula III
to form the anabaenopeptin or derivative thereof having formula IV:
wherein:
R is C1-10 alkyl, phenyl, or nitrophenyl; and
R′ is a C4-20 hydrocarbon group that includes an ester moiety, a C4-20 alkyl, C6-20 aryl, or a C7-20 alkyl aryl.

### Claim 24 (depends on 23)

The method of claim 23 wherein the compound having formula III is selected from the group consisting of:

### Claim 25 (depends on 1)

A method for forming an anabaenopeptin or derivative thereof, the method comprising:
a) converting the compound having formula of claim 1 into an isocyanate having formula V:
and
b) reacting the compound having formula V with an amine.

### Claim 26 (depends on 25)

The method of claim 25 wherein in step a) the compound having formula I is reacted with triphosgene or triphosgene and a base to form the compound having formula V.

### Claim 27 (depends on 25)

The method of claim 25 wherein the amine has formula VI:
where R8 is a C4-20 hydrocarbon group that includes an ester moiety, a C4-20 alkyl, C6-20 aryl, or a C7-20 alkyl aryl.

### Claim 28 (depends on 1)

A method for forming an anabaenopeptin or derivative thereof, the method comprising:
a) reacting the compound of claim 1 with a compound having formula III
to form the anabaenopeptin or derivative thereof having formula VII:
wherein:
R9 is a C4-20 hydrocarbon group, a C4-20 alkyl, C6-20 aryl, or a C7-20 alkyl aryl; and
R′ is a C4-20 hydrocarbon group that includes an ester moiety, a C4-20 alkyl, C6-20 aryl, or a C7-20 alkyl aryl.
